Discover the factors behind UnitedHealth's recent stock plunge and what it means for investors. Is UNH still a viable ...

The first half of 2025 was a tumultuous time for U.S. securities, to put it mildly. The transition to the second Trump administration brought rapidly shifting domestic and international policies ...

CI's commercial focus and clearer outlook set it apart as UNH faces guidance pulls, CEO change and rising medical costs.

The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

UnitedHealth Group (UNH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The Justice Department is investigating UnitedHealth’s Medicare billing practices, focusing on diagnosis coding and doctor ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...

Complete UnitedHealth Group Inc. stock information by Barron's. View real-time UNH stock price and news, along with industry-best analysis.

Insights from CNBC's Halftime Report Final Trades on industrial, healthcare sectors and e-commerce potential, with stock ...